340 related articles for article (PubMed ID: 20975375)
21. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
[TBL] [Abstract][Full Text] [Related]
22. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
[TBL] [Abstract][Full Text] [Related]
23. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
24. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
[TBL] [Abstract][Full Text] [Related]
25. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
Patnaik S; Mallick R; Kannisto E; Sharma R; Bshara W; Yendamuri S; Dhillon SS
J Thorac Oncol; 2015 Mar; 10(3):446-53. PubMed ID: 25695220
[TBL] [Abstract][Full Text] [Related]
26. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
31. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.
Fassina A; Cappellesso R; Fassan M
Chest; 2011 Nov; 140(5):1305-1311. PubMed ID: 21622546
[TBL] [Abstract][Full Text] [Related]
32. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
33. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
34. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.
Harada H; Miyamoto K; Yamashita Y; Taniyama K; Mihara K; Nishimura M; Okada M
Cancer Med; 2015 Oct; 4(10):1536-46. PubMed ID: 26276761
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
38. Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.
Shen H; Shen J; Wang L; Shi Z; Wang M; Jiang BH; Shu Y
Biomed Pharmacother; 2015 Feb; 69():301-5. PubMed ID: 25661374
[TBL] [Abstract][Full Text] [Related]
39. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]